Company: BGLC
Filing Date: 2025-11-07
Form Type: S-3
Source: 0001477932-25-007976
Chunk: 29

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-07
Form: S-3
Chunk 29
---
 quarterly periods ended March 31, 2025 and June 30, 2025, filed with the SEC on May 15, 2025 and August 18, 2025, respectively;                                                                                                                                                                                                                                                                                          |
|:--|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ● | our Current Reports on Form 8-K filed with the SEC on January 2, 2025, February 14, 2025, March 25, 2025, April 3, 2025, April 10, 2025, April 30, 2025 (excluding the information under Item 7.01 and Exhibit 99.1), and June 23, 2025;                                                                                                                                                                                                                            |
| ● | our Form 8-A12B, filed with the SEC on July 19, 2023; and                                                                                                                                                                                                                                                                                                                                                                                                           |
| ● | the description of the Company’s shares of Common Stock under the heading “Description of Capital Stock” contained in the Registration Statement on Form S-1 (File No. 333-269753), as originally filed on February 14, 2023 and as amended, and in the related prospectus filed pursuant to Rule 424(b) on July 21, 2023, each of which is incorporated herein by reference, including any amendment or report filed for the purpose of updating such description. |

All reports and other documents that we subsequently file with the SEC (excluding any portions of such documents that have been “furnished to” but not “filed with” the SEC) pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus supplement and before the later of (1) the completion of the offering of our common stock pursuant to this prospectus supplement and (2) the date we stop offering our common stock pursuant to this prospectus supplement, will be deemed to be incorporated by reference into this prospectus supplement and to be part of this prospectus supplement from the date of filing of such reports and documents. These documents include periodic reports, such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as proxy statements. We will not, however, incorporate by reference in this prospectus any documents or portions thereof that are not deemed “filed” with the SEC, including any information furnished pursuant to Item 2.02 or Item 7.